Phage-dependent superproduction of biologically active protein and peptides

Details for Australian Patent Application No. 2001284914 (hide)

International Classifications

Event Publications

2 February 2006 Assignment before Grant

Phage Biotechnology Corporation The application has been assigned to Phage Biotechnology Corporation; Cardio Vascular BioTherapeutics, Inc.

9 February 2006 Application Accepted

Published as AU-B-2001284914

8 June 2006 Standard Patent Sealed

26 August 2010 Assignment Registered

Cardio Vascular BioTherapeutics, Inc.; Phage Biotechnology Corporation The patent has been assigned to New Technologies Holdings Pte Ltd

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.